← All trials
NCT01379326
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2011
- Primary completion
- Dec 1, 2012
- Completion date
- Dec 1, 2012
- First posted
- —
- Last posted
- —
- Enrollment
- 250
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Ghent UniversityLead sponsor
- University of NottinghamCollaborator
- World Health OrganizationCollaborator
- National Institute of Malariology, Parasitology and Entomology, VietnamCollaborator
- Jimma UniversityCollaborator
- Institut PasteurCollaborator
- Fundacion HuespedCollaborator
- Commonwealth Scientific and Industrial Research Organisation, AustraliaCollaborator
- Ivo de Carneri, Pemba Island, TanzaniaCollaborator
- University of QueenslandCollaborator
- University of YaoundeCollaborator
- Oswaldo Cruz FoundationCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.